According to age and gender, seventeen, eleven, eight and four data clusters were extracted to evaluated the pooled HRs of all-cause, CV disease-related, cancer-related, and liver disease-related mortality, compared between participants with higher and lower ALT levels respectively (in overall, younger, and older subgroups; Figure 1). The gene discussed is GPT; the disease is liver disorder.